288 related articles for article (PubMed ID: 26881476)
1. Factor XIa inhibitors: A review of the patent literature.
Al-Horani RA; Desai UR
Expert Opin Ther Pat; 2016; 26(3):323-45. PubMed ID: 26881476
[TBL] [Abstract][Full Text] [Related]
2. Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present).
Al-Horani RA
Expert Opin Ther Pat; 2020 Jan; 30(1):39-55. PubMed ID: 31847619
[No Abstract] [Full Text] [Related]
3. Recent advances in the discovery and development of factor XI/XIa inhibitors.
Al-Horani RA; Afosah DK
Med Res Rev; 2018 Sep; 38(6):1974-2023. PubMed ID: 29727017
[TBL] [Abstract][Full Text] [Related]
4. Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.
Al-Horani RA; Gailani D; Desai UR
Thromb Res; 2015 Aug; 136(2):379-87. PubMed ID: 25935648
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212).
Pinto DJP; Orwat MJ; Smith LM; Quan ML; Lam PYS; Rossi KA; Apedo A; Bozarth JM; Wu Y; Zheng JJ; Xin B; Toussaint N; Stetsko P; Gudmundsson O; Maxwell B; Crain EJ; Wong PC; Lou Z; Harper TW; Chacko SA; Myers JE; Sheriff S; Zhang H; Hou X; Mathur A; Seiffert DA; Wexler RR; Luettgen JM; Ewing WR
J Med Chem; 2017 Dec; 60(23):9703-9723. PubMed ID: 29077405
[TBL] [Abstract][Full Text] [Related]
6. A review of emerging factor XI inhibitors.
Elsheikh S; Tidbury N; Lip GYH
Expert Opin Emerg Drugs; 2023 Mar; 28(1):43-53. PubMed ID: 36927160
[TBL] [Abstract][Full Text] [Related]
7. A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.
Al-Horani RA; Abdelfadiel EI; Afosah DK; Morla S; Sistla JC; Mohammed B; Martin EJ; Sakagami M; Brophy DF; Desai UR
J Thromb Haemost; 2019 Dec; 17(12):2110-2122. PubMed ID: 31397071
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
[TBL] [Abstract][Full Text] [Related]
9. Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors.
Argade MD; Mehta AY; Sarkar A; Desai UR
J Med Chem; 2014 Apr; 57(8):3559-69. PubMed ID: 24666186
[TBL] [Abstract][Full Text] [Related]
10. Targeting factor XI and factor XIa to prevent thrombosis.
Gailani D; Gruber A
Blood; 2024 Apr; 143(15):1465-1475. PubMed ID: 38142404
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of factor XIa as a new approach to anticoagulation.
Schumacher WA; Luettgen JM; Quan ML; Seiffert DA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):388-92. PubMed ID: 20139363
[TBL] [Abstract][Full Text] [Related]
12. Fragment-Based Lead Generation of 5-Phenyl-1
Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma.
Modrzycka S; Kołt S; Adams TE; Potoczek S; Huntington JA; Kasperkiewicz P; Drąg M
J Med Chem; 2023 Mar; 66(6):3785-3797. PubMed ID: 36898159
[TBL] [Abstract][Full Text] [Related]
14. Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors.
Yao N; Jia Z; Tian Y; Hou S; Yang X; Han J; Duan Y; Liao C; Kong Y; Xie Z
J Med Chem; 2022 Mar; 65(5):4318-4334. PubMed ID: 35220720
[TBL] [Abstract][Full Text] [Related]
15. Discovery methods of coagulation-inhibiting drugs.
Gómez-Outes A; García-Fuentes M; Suárez-Gea ML
Expert Opin Drug Discov; 2017 Dec; 12(12):1195-1205. PubMed ID: 28952381
[TBL] [Abstract][Full Text] [Related]
16. Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week.
Harrington J; Piccini JP; Alexander JH; Granger CB; Patel MR
J Am Coll Cardiol; 2023 Feb; 81(8):771-779. PubMed ID: 36813377
[TBL] [Abstract][Full Text] [Related]
17. Targeting factor XI(a) for anticoagulation therapy: a patent landscape.
Al-Horani RA
Pharm Pat Anal; 2020 Jan; 9(1):3-5. PubMed ID: 32057285
[No Abstract] [Full Text] [Related]
18. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.
Kar S; Mottamal M; Al-Horani RA
ChemistryOpen; 2020 Nov; 9(11):1161-1172. PubMed ID: 33204588
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulants.
Hussain Z; Cooke AJ; Neelamkavil S; Brown L; Carswell E; Geissler WM; Guo Z; Hawes B; Kelly TM; Kiyoi Y; Lai K; Lesburg C; Pow E; Zang Y; Wood HB; Edmondson SD; Liu W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127072. PubMed ID: 32340773
[TBL] [Abstract][Full Text] [Related]
20. Sulfonated non-saccharide molecules and human factor XIa: Enzyme inhibition and computational studies.
Al-Horani RA; Parsaeian E; Mohammad M; Mottamal M
Chem Biol Drug Des; 2022 Jul; 100(1):64-79. PubMed ID: 35377529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
